Lupin Ltd - 500257 - Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31, 2025 And Recommend Final Dividend Of Rs. 12/- Per Equity Share I.E. 600 % Of The Face Value Of Rs. 2/ Each Fully Paid Up For The Financial Year Ended March 31, 2025

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer

1933.4000 11.30 (0.59%)

NSE Jul 09, 2025 09:07 AM

Volume: 8,466

Lupin Ltd.

14 May 2025

1933.40

0.59%

Result

Lupin Ltd - 500257 - Approval Of The Audited Financial Statements For The Quarter And Year …

BSE India

Approval of the Audited Financial Statements for the quarter and year ended March 31, 2025 and recommend the Final Dividend of Rs. 12/- per Equity Share i.e. 600 % of the Face Value of Rs. 2/- each fully paid up for the financial year ended March 31, 2025.

pdf